"Mount Miriam is the home to the best and biggest clinical oncology and cancer care team in the region with cutting-edge robotic radiosurgery – Cyberknife. Mount Miriam, a place where the excellence in cancer care and affordable treatment meets."

During the past decade, Mount Miriam Cancer Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mount Miriam Cancer Hospital" #1 sponsor was "Arcus Biosciences, Inc." with 1 trials, followed by "Eli Lilly and Company" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Miriam Cancer Hospital" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Mount Miriam Cancer Hospital" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Lung Cancer" (1 trials), "Metastatic Breast Cancer" (1 trials), "Non Small Cell Lung Cancer" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Mount Miriam Cancer Hospital" in a lesser frequency.

Most popular intervention types in "Mount Miriam Cancer Hospital" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Paclitaxel" (2 trials), "Pemetrexed" (2 trials), "Abemaciclib" (1 trials) and "Amivantamab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mount Miriam Cancer Hospital" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Mount Miriam Cancer Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Mount Miriam Cancer Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mount Miriam Cancer Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".